Wearable Device For Feeding and Observing Birds and Other Flying Animals
A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7432243 | Truncated 24kDa basic fibroblast growth factor The invention relates to fragments of an amino acid sequence of mature, full length 24 kDa fibroblast growth factor-2 or an analog thereof. The fragments have an activity that inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth,... | 10/07/2008 |
| 7407938 | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use One embodiment of the invention relates to compounds of the formula I, in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification. Other embodiments of the invention relate to physiologically acceptable... | 08/05/2008 |
| 7235543 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituen... | 06/26/2007 |
| 7208486 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituen... | 04/24/2007 |
| 7192944 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituen... | 03/20/2007 |
| 6890531 | Neuronal growth factor galectin-1 This invention relates to a remedy for neuropathy, such as nerve injury, nerve degeneration, and hypofunction upon nerve grafting, which contains as the active ingredient galectin-1 having an amino acid sequence represented by SEQ ID NO:1 or its derivative; a protei... | 05/10/2005 |
| 6664367 | Stable analogs of bioactive peptides containing disulfide linkages Stable analogs of cyclic peptides containing disulfide linkages are disclosed. The disulfide linkage is modified by one of four methods: (a) sulfide contraction, (b) isosteric substitution, (c) thioketal expansion, or (d) alkylation expansion. In sulfide ... | 12/16/2003 |
| 6130204 | Peptides Oligopeptides which comprise amino acid sequences that are recognized and proteolytically cleaved by free prostate specific antigen (PSA) are described. Also described are assays which comprise such oligopeptides useful for determining free PSA protease a... | 10/10/2000 |
| 5948889 | Compositions and methods for screening antimicrobials A method for screening compounds for antimicrobial activity is described that utilizes bacterial protein-protein binding in vitro. The method may be performed using immobilized elements and the immobilization may be carried out using a variety of immobili... | 09/07/1999 |
| 5866683 | Isoelectric point markers for isoelectric focusing with fluorescence detection Provided are isoelectric point(pI) markers for isoelectric focusing with fluorescence detection. The markers are fluorescence-labeled oligopeptides which comprise a fluorescence dye bonded chemically to the amino group of N-terminal amino acid of oligopep... | 02/02/1999 |
| 5443815 | Technetium-99m labeled peptides for imaging The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind Tc-99m and which can be targeted to specific site... | 08/22/1995 |
| 5350574 | Derivatives of cyclosporina A, antibodies directed thereto and uses thereof This invention provides a molecule comprising cyclosporine A or a congener of cyclosporine A which is photochemically attached to a ligand containing a reactive group. This invention also provides a composition of matter which comprises a conjugate of a c... | 09/27/1994 |
| 5243030 | Conjugates of a synthetic peptide for diagnosis and prevention of influenza virus infection Macromolecular conjugates of a synthetic polypeptide having influenza virus antigenic properties are disclosed. These conjugates contain a polypeptide corresponding substantially to the 215-235 region of the matrix protein (M-protein) of influenza virus.... | 09/07/1993 |
| 5217705 | Method of diagnosing blood clots using fibrin-binding proteins A fibrin-binding protein such as t-PA is labeled with a detectable substance, such as a radionuclide, and administered to a patient for diagnosis of blood clots and for monitoring the dissolution thereof during therapy. The detectable substance preferably... | 06/08/1993 |
| 5132111 | CRF analog conjugates Agonists and antagonists of rCRF are disclosed that exhibit good binding affinity to CRF receptors. One exemplary agonist is: H-Ser-Gln-Glu-Pro-Pro-Ile-Ser- Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met- Ala-Arg-Ala-Glu-Gln-Glu-Ala-Glu-Gln-... | 07/21/1992 |
| 4855486 | Blocked, marked amino acids A method is provided for quantitatively monitoring the deprotection and coupling reactions employed in the solid phase synthesis of peptides. The method entails synthesizing a peptide on a support matrix that has a first marker associated therewith. The a... | 08/08/1989 |
| 4771123 | Peptide thioneamides as selective substrates for cysteine proteases Peptide thioneamides are provided as synthetic substrates for cysteine proteases. The compounds of the invention are peptides consisting of one or more blocked or unblocked amino acids wherein the terminal carboxy of the peptides are thionated and forms a... | 09/13/1988 |
| 4769445 | Process for the solid phase synthesis of peptides which contain sulfated tyrosine Peptides and Peptide amides such as cholecystokinin (CCK-8) are synthesized in improved yields and purity by a solid phase process. The requisite protected peptide is elaborated and sulfated on a solid support, deprotected, and cleaved from the solid supp... | 09/06/1988 |
| 4767842 | Antigenic modification of polypeptides Endogenous and exogenous proteins, and fragments thereof, are chemically modified outside the body of an animal so that when injected into the animal they produce more antibodies against the unmodified protein than would injection of the unmodified protei... | 08/30/1988 |
| 4767628 | Continuous release pharmaceutical compositions Pharmaceutical compositions, comprising a polylactide and a pharmacologically active, acid stable polypeptide, which when placed in an aqueous physiological environment release the polypeptide at an approximately constant rate in an essentially monophasic... | 08/30/1988 |
| 4762913 | Antigenic modification of polypeptides Endogenous and exogenous proteins, and fragments thereof, are chemically modified outside the body of an animal so that when injected into the animal they produce more antibodies against the unmodified protein than would injection of the unmodified protei... | 08/09/1988 |
| 4755558 | Using internal marker A method is provided for quantitatively monitoring the deprotection and coupling reactions employed in the solid phase synthesis of peptides. The method entails synthesizing a peptide on a support matrix that has a first marker associated therewith. The a... | 07/05/1988 |
| 4755462 | Analytical process and agents for the detection of esterolytic and/or proteolytic enzymes Agent for the detection of esterolytic and/or proteolytic enzymes, containing (a) an amino acid ester or peptide ester of a phenol, as the chromogenic enzyme substrate, and (b) a substance which accelerates the enzymatic cleavage of the amino acid ester o... | 07/05/1988 |
| 4753984 | Water soluble macromolecular prodrugs, their preparation and their use as antitumor and antiparasite medicines A prodrug comprises a polyhydroxylated polyamine to which a drug is linked by the intermediary of a peptidyl group. The prodrug is useful as an antitumor or antiparasite medicine.... | 06/28/1988 |
| 4748116 | Peptide substrates for determination of protease activity Peptide sequences consisting of 2-4 amino acids with high affinity and comparatively high specificity to a number of various, physiologically important proteases are known to have been synthetized before. Such sequences with an added C-terminal marker hav... | 05/31/1988 |
| 4717658 | Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL) A screening method for the determination of 104 gram negative bacteria per milliliter of an undiluted urine sample and a unitary screening test device for the determination of at least 105 gram negative bacteria per milliliter of an ... | 01/05/1988 |
| 4703107 | Water-soluble acylated derivatives of peptides or amino acids, their preparation and their use Peptide derivatives of aminodrugs have longer lasting effects than the drugs without the peptide radical.... | 10/27/1987 |
| 4703004 | Synthesis of protein with an identification peptide A hybrid polypeptide composed of an identification peptide and a desired functional protein are produced by recombinant DNA techniques. A DNA expression vector is constructed that includes segments of DNA coding for the identification peptide and the desi... | 10/27/1987 |
| 4701499 | Synthesis of N-substituted peptide amides Peptide N-alkylamides, and other C-terminal N-substituted amides, can be synthesized using solid-phase synthesis on a benzene-containing resin which is suitably methylated. Reactive amino groups are attached directly or indirectly to the methyl groups, fo... | 10/20/1987 |
| 4694070 | Water soluble xanthylium derivatives substrates Water soluble xanthylium derivative substrates of rhodamine 110 and rhodol permit spectrophotometric and fluorescent measurements of trypsin-like enzymes without the addition of organic solvent additives and/or special water solubilizing agents. These nov... | 09/15/1987 |
| 4665016 | Chromogenic compounds, a process for their preparation and their use Chromogenic compounds of the formula I ##STR1## and a process for their preparation are described, X denoting a hydrogen atom, a protective group customarily used in peptide chemistry or a group which irreversibly blocks the terminal amino group, A a... | 05/12/1987 |
| 4639456 | Vinblastin-23-oyl amino acid derivatives Vinblastine derivatives of the formula ##STR1## wherein R1 is an ester of a -aminoacid selected from the group consisting of glycine, alanine, valine, leucine, isoleucine, serine, threonine, aspartic acid, glutamic acid, aspargine, ... | 01/27/1987 |
| 4634682 | Radioimmunoassays for the serum thymic factor (FTS) Radioimmunossays for the quantitation of serum thymic factor (FTS), a thymic peptide hormone, are disclosed. Each assay employs an antibody specific for FTS, the monoclonal antibody or the antibody from the antiserum of a host animal; synthetic FTS or FTS... | 01/06/1987 |
| 4629695 | Peptide derivatives and use thereof as substrates for quantitatively assaying enzymes Peptide derivatives of formula ##STR1## wherein R1 represents a substituted amino group which is capable of being split off enzymatically with formation of a colored or fluorescent compound R1 -H. The said peptide derivatives ar... | 12/16/1986 |
| 4593073 | Polymer resins with amino acid containing pendants for sorption of bile pigments and bile acids The invention is concerned with a novel polymer addition product comprising hydrophilic polymer backbone having a molecular weight of at least about 5,000 and to which are attached amino acid containing pendants, the pendants containing at least one argin... | 06/03/1986 |
| 4587046 | Drug-carrier conjugates Biologically active drugs, e.g. catecholamine hormones, are coupled to carrier molecules, e.g. monodisperse peptides to produce conjugate molecules. The conjugate molecules retain biological activity, but the pharmacokinetic, pharmacodynamic and/or potenc... | 05/06/1986 |
| 4563305 | Radiolabelled substrates for assaying mammalian enzymes Compounds which are substrates for mammalian enzymes, especially proteolytic and peptidase enzymes, are disclosed. These compounds, in general, have the general formula X-T, W-Y or X-(Pep)-Y, wherein X is a radiolabelled benzoyl or hydroxyphenylpropanoyl ... | 01/07/1986 |
| 4537716 | Des-serine2 or des-glycine2 -leucine22 calcitonin New peptides are disclosed which have biological activity of the same type as known calcitonins and which have a shorter amino acid chain than natural calcitonins and are also substitution analogs of the natural calcitonins. Also resin peptides are disclo... | 08/27/1985 |
| 4517303 | Specific binding assays utilizing analyte-cytolysin conjugates A novel analyte-cytolysin conjugate and its use in a lipid vesicle mediated measurement process is described for a wide variety of analytes present at very low concentration. The method involves forming a reaction system consisting of analyte, analyte spe... | 05/14/1985 |
| 4515920 | Synthesis of peptides and proteins Solid phase synthesis of peptides and proteins have been improved by the use of a trifunctional segment, one functional group of which is bound to a solid support, the other two functional groups being available as substrates upon which identical proteins... | 05/07/1985 |